About Biotest AG

Company Description

Biotest is a global company that supplies plasma protein products and biotherapeutic drugs. Our products are primarily used in the therapeutic areas of clinical immunology, haematology and intensive care medicine. For patients with serious and often chronic diseases they provide targeted treatment, which generally enable them to lead almost normal lives.
Within our areas of specialisation, we start from pre-clinical and clinical development to manufacturing and global marketing. Research, development and production are carried out at our main headquarters in Germany. Our own sales organisations (subsidiaries) and cooperating partners represent our global distribution network.

Year founded

1946

Served area

Worldwide

Headcount

1,663

Headquarters

Landsteinerstraße 5, 63303 Dreieich – Germany

Publications

Insider Trades

Date Trading entity / Person Association Trade type Volume Average price
29.11.21 Bernöster, Dr. Katrin Other Sell 15,640.00 € 29.11.21
29.11.21 Realsoul Holding S.A. Close relation Buy 1,713.60 € 29.11.21
18.11.21 Moritz, Michael Other Sell 35,460.00 € 18.11.21
18.11.21 Schüttrumpf, Dr. Jörg Other Sell 99,895.50 € 18.11.21
18.11.21 Fleck, Stephan Other Sell 120,870.00 € 18.11.21
18.11.21 Reinecke, Dr. Martin Other Sell 37,715.00 € 18.11.21

Shareholder information

Shares outstanding

19,785,726

IPO

Jan. 1, 1987

Stock exchange(s)

Frankfurt Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.